Connor, Clark & Lunn Investment Management (CC&L)
CCCC icon

Connor, Clark & Lunn Investment Management (CC&L)’s C4 Therapeutics CCCC Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CCCC Stock Details CCCC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$72K Buy
2024
Q2 		– Sell
2024
Q1 		$1.42M Buy
2023
Q4 		$950K Buy
2023
Q3 		$306K Sell
2023
Q2 		$479K Buy
2023
Q1 		$358K Buy
2022
Q4 		$85.3K Buy